Latest Articles
- ArticleEvaluating more naturalistic outcome measuresA 1-year smartphone study in multiple sclerosisRiley Bove, Charles C. White, Gavin Giovannoni, et al.October 15, 2015
- ArticleLeptomeningeal contrast enhancement and blood-CSF barrier dysfunction in aseptic meningitisAngelika Alonso, Philipp Eisele, Anne D. Ebert, et al.October 15, 2015
- ArticleReduction of microbleeds by immunosuppression in a patient with Aβ-related vascular inflammationAndreas Traschütz, Theophilos Tzaridis, Arndt-Hendrik Penner, et al.October 15, 2015
- Editor's CornerName a brain protein, and an autoantibody shall be found!Josep DalmauOctober 08, 2015
- Clinical/Scientific NotesAntibodies to aquaporin-1 are not present in neuromyelitis opticaKathrin Schanda, Patrick Waters, Hannah Holzer, et al.October 01, 2015
- ArticleNo evidence for higher risk of cancer in patients with multiple sclerosis taking cladribineJulia Pakpoor, Giulio Disanto, Daniel R. Altmann, et al.October 01, 2015
- ArticleBasal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizuresEoin P. Flanagan, Amy L. Kotsenas, Jeffrey W. Britton, et al.October 01, 2015
- Clinical/Scientific NotesPlasticity-related gene 5: A novel surface autoantigen in paraneoplastic cerebellar degenerationMarleen H. van Coevorden-Hameete, Esther de Graaff, Maarten J. Titulaer, et al.September 24, 2015
- ArticlePharmacogenomic study in patients with multiple sclerosisResponders and nonresponders to IFN-βMarta F. Bustamante, Carlos Morcillo-Suárez, Sunny Malhotra, et al.September 24, 2015
- EditorialSubtype-specific therapy for autoimmune neuropathies?Eric Lancaster, Steven S. SchererSeptember 24, 2015
Pages
Advertisement